Strengthening Cancer Care through Quality Manufacturing
The growing global burden of cancer has significantly increased the demand for high-quality, affordable oncology medicines. India has emerged as a key player in this space, with several pharmaceutical hubs contributing to cancer drug production. Among them, Delhi holds a strategic position due to its advanced infrastructure, regulatory ecosystem, and proximity to major healthcare and research institutions. As a result, oncology medicine manufacturers in Delhi, India play a vital role in strengthening both domestic and international cancer care supply chains. India’s Role in Oncology Drug Manufacturing India is widely recognized as the “pharmacy of the world,” supplying cost-effective and quality-assured medicines to over 200 countries. In oncology, Indian manufacturers produce a wide range of products including oral solid dosage forms, injectables, cytotoxic drugs, and targeted cancer therapies. Strict adherence to global quality standards such as WHO-GMP, ISO certifications...